Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Sep
1
2023
Seventh Circuit Follows Illinois Supreme Court Precedent and Finds BIPA Claims Timely Vedder Price
Sep
1
2023
Reclassifying Cannabis as a Schedule III Substance – Will the DEA Agree? Sheppard, Mullin, Richter & Hampton LLP
Sep
1
2023
Kraft Heinz Agrees to Settle Suit Over Malic Acid Flavoring Keller and Heckman LLP
Sep
1
2023
Alabama Medical Cannabis Licensing Program Halted (Again): Is the Levee Goin’ to Break? Bradley Arant Boult Cummings LLP
Sep
1
2023
Medical Supplier Agrees to Pay $29 Million for FCA Violations ArentFox Schiff LLP
Aug
31
2023
Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking Nelson Mullins
Aug
31
2023
FDA Issues Warning Letters to Three Infant Formula Manufacturers Keller and Heckman LLP
Aug
31
2023
Does the End Justify the Means? Privacy Advocates React to the Cooper Davis Act Bradley Arant Boult Cummings LLP
Aug
31
2023
Smoke ‘Em if You Got ‘Em (OK, Not Just Yet): Feds Recommend Rescheduling Marijuana Bradley Arant Boult Cummings LLP
Aug
31
2023
No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success McDermott Will & Emery
Aug
31
2023
Alert: US DHHS Recommends Moving Cannabis to Schedule III Womble Bond Dickinson (US) LLP
Aug
31
2023
PFAS AFFF MDL Settlements Moving Forward CMBG3 Law
Aug
31
2023
Aspartame Safety Review by the WHO: a Short Story about a Tempest in a Teapot… Keller and Heckman LLP
Aug
30
2023
Demand Heats Up for Biochar Carbon Projects Beveridge & Diamond PC
Aug
30
2023
Largest U.S. E-Cigarette Clinical Trial Confirms Role in Smoking Cessation Keller and Heckman LLP
Aug
30
2023
COVID-19 Fall Outlook Bradley Arant Boult Cummings LLP
Aug
29
2023
FDA Signs Regulatory Partnership Arrangement with Ecuador Covering Shrimp Imports Keller and Heckman LLP
Aug
28
2023
Expert Testimony Rejected in California Heavy Metals Baby Food Lawsuit Keller and Heckman LLP
Aug
28
2023
TTB Issues Updated Guidance on Transfers of Beer Between Breweries Under Separate Ownership McDermott Will & Emery
Aug
25
2023
FDA’s Office of Prescription Drug Promotion Issues Second Untitled Letter of the Year to Exeltis for Misleading Statements Relating to SLYND® Sheppard, Mullin, Richter & Hampton LLP
Aug
25
2023
FDA Proposes to Amend Canned Tuna Standard Keller and Heckman LLP
Aug
25
2023
The Generative AI Revolution: Key Legal Considerations for the Cannabis Industry ArentFox Schiff LLP
Aug
24
2023
China Bans Seafood from Japan Keller and Heckman LLP
Aug
24
2023
How to Introduce Alternative Proteins via Tasting Trials in the Netherlands and Singapore Keller and Heckman LLP
Aug
24
2023
New York Cannabis Lawsuit Overview and Possible Effects on the Much-Anticipated Adult-Use Cannabis License Application Period Epstein Becker & Green, P.C.
Aug
24
2023
Tenth Circuit Reaffirms Preemption of State Pharmacy Network Regulations McDermott Will & Emery
Aug
23
2023
“On the Go” Ice Cream Cups Recalled Due to Listeria Contamination Keller and Heckman LLP
Aug
23
2023
SuperValu’s Effect on the FCA Scienter Standard and Impact to Future Litigation Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins